Key Take Aways from IMS 2023 | Rafael Fonseca, MD | IMS 2023

Key Take Aways from IMS 2023 | Rafael Fonseca, MD | IMS 2023
Impact of Racial Disparities in Myeloma | Doctors Cole and Kumar | IMS 2023
Update from IMS on Novel Technologies in Multiple Myeloma | Gareth Morgan, MD, PhD | IMS 2023
Monoclonal Gammopathy of Unknown Significance | Urvi Shah, MD | IMS 2023
Using a Single Cell Approach to Define Mechanisms of Progression | Irene Ghobrial, MD | IMS 2023
Serial MRD Assessments as a Surrogate for Long Term PFS | Frits van Rhee, MD | IMS 2023
Sustained MRD Negativity in Transplant Eligible Patients | Camila Guerrero, PhD | IMS 2023
Treatment Options for Frail Patients at Early Relapse | Paul Richardson, MD | IMS 2023
Benefits of Healthy Living, 7th Nursing & Allied Health Conference | Beth Faiman, PhD, CNP | IMS 2023
OPTIMISMM Trial for Myeloma | Meral Beksac, MD | IMS 2023